๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Predictors of the rate of decline of residual renal function in incident dialysis patients

โœ Scribed by Jansen, Maarten A.M. (author);Hart, Augustinus A.M. (author);Korevaar, Johanna C. (author);Dekker, Friedo W. (author);Boeschoten, Elisabeth W. (author);Krediet, Raymond T. (author);Birnie, R. J. (author);Boekhout, M. (author);Boer, W. H. (author);van Buren, M. (author);Buller, H. R. (author);De Charro, F. Th (author);Doorenbos, C. J. (author);Van Dorp, W. T. (author);Van Den Dorpel, M. A. (author);Van Es, A. (author);Feith, G. W. (author);Frenken, L. A.M. (author);Van Geelen, J. A.C.A. (author);Gerlag, P. G.G. (author);Gorgels, J. P.M.C. (author);Grave, W. (author);Hagen, E. C. (author);De Heer, F. (author);Hoorntje, S. J. (author);Huisman, R. M. (author);Jager, K. J. (author);Jie, K. (author);Keur, I. (author);Koning-Mulder, W. A.H. (author);Koolen, M. I. (author);Hovinga, T. K.Kremer (author);Lavrijssen, A. T.J. (author);Luik, A. J. (author);Van Manen, J. G. (author);Van Der Meulen, J. (author);Parlevliet, K. J. (author);Rosman, J. B. (author);Van Der Sande, F. (author);Schonck, M. J.M. (author);Schuurmans, M. M.J. (author);Stege-Man, C. A. (author);Stevens, P. (author);Tijssen, J. G.P. (author);Valentijn, R. M. (author);Vastenburg, G. (author);Verburgh, C. A. (author);Verhagen, C. E. (author);Vincent, H. H. (author);Vos, P. (author);Wolters, J. (author)


Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
108 KB
Volume
62
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background:

Residual renal function (rrf) influences morbidity, mortality and quality of life in chronic dialysis patients. few studies have been published on risk factors for loss of rrf in dialysis patients. these studies were either retrospective, performed in a small number of patients, or estimated gfr without a urine collection.

Methods:

We analyzed the decline rates of residual gfr (rgfr) prospectively in 522 incident hd and pd patients who had structured follow-up assessments. gfr was measured as the mean of urea and creatinine clearance, calculated from urine collections. the initial value was obtained 0 to 4 weeks before the start of dialysis. the measurements were repeated 3, 6, and 12 months after the start of dialysis treatment. after logarithmic transformation, differences in rgfr changes over time were analyzed using repeated measurement analysis of variance.

Results:

Baseline factors that were negatively associated with rgfr at 12 months were a higher diastolic blood pressure (p < 0.001) and a higher urinary protein loss (p < 0.001). primary kidney disease did not affect rgfr. averaged over time, pd patients had a higher rgfr (p < 0.001) than hd patients. this relative difference increased over time (p = 0.04). investigation of possible effects of the dialysis procedure on the decline rate between 0 and three months showed that dialysis hypotension (p = 0.02) contributed to the decline in hd and the presence of episodes with dehydration contributed in pd (p = 0.004).

Conclusions:

Rgfr is better maintained in pd patients than in hd patients. the associated factors such as a higher diastolic blood pressure, proteinuria, dialysis hypotension and dehydration can either be treated or avoided.


๐Ÿ“œ SIMILAR VOLUMES


Rate of decline in renal function in Ind
โœ Koppiker, N.; Feehally, J.; Raymond, N.; Abrams, K.R.; Burden, A.C. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 87 KB ๐Ÿ‘ 1 views

The incidence of end-stage renal failure (ESRF) is higher in the Indo-Asian ethnic group as compared to the White. To investigate whether this might be associated with faster rates of progression to ESRF in Indo-Asian diabetic patients, we studied a total of 39 Type 2 diabetic patients, using the De

Prevention of decline in renal function
โœ M. P. Cohen; R. S. Clements; J. A. Cohen; C. W. Shearman ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Springer ๐ŸŒ English โš– 520 KB

We recently reported that when diabetic db/db mice, which develop glomerular pathology resembling that in human diabetes mellitus, are treated with monoclonal antibodies (A717) that neutralize the effects of excess glycated albumin, there is an amelioration of mesangial expansion, renal overexpressi